Trexquant Investment LP Bluebird Bio, Inc. Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $198,239 - $370,377	-17,637 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$18.04 - $22.09 $318,171 - $389,601	17,637 New	17,637 $564,000
Q4 2020 Feb 11, 2021	SELL	$27.5 - $37.92 $248,765 - $343,024	-9,046 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$34.44 - $43.75 $590,577 - $750,225	-17,148 Reduced 65.47%	9,046 $488,000
Q2 2020 Aug 07, 2020	SELL	$27.12 - $45.97 $82,987 - $140,668	-3,060 Reduced 10.46%	26,194 $1.6 Million
Q1 2020 May 08, 2020	BUY	$26.16 - $63.5 $765,284 - $1.86 Million	29,254 New	29,254 $1.35 Million
Q1 2018 May 03, 2018	SELL	$105.8 - $150.94 $843,543 - $1.2 Million	-7,973 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$81.25 - $130.7 $647,806 - $1.04 Million	7,973	7,973 $1.42 Million

142

63.2M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $605M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.